Recent discussions surrounding the EU Artificial Intelligence Act have accelerated as the European Parliament took the Act one step closer to becoming effective law.
On June 14, 2023, the Parliament voted for negotiations...more
Navigating the complex landscape of drug discovery requires innovative strategies and interdisciplinary collaborations spanning biotechnology, pharmacology, medicine and engineering.
As the cost of developing new drugs...more
7/19/2023
/ Artificial Intelligence ,
Biopharmaceutical ,
Biotechnology ,
Copyright ,
Data Protection ,
Data-Sharing ,
Healthcare ,
Innovative Technology ,
Intellectual Property Protection ,
Joint Ownership ,
Licenses ,
Life Sciences ,
Machine Learning ,
Patent Ownership ,
Patents ,
Pharmaceutical Industry ,
Prescription Drugs ,
Technology Sector ,
Trademarks
The energy and excitement have not worn off from our attendance at CES 2023 in Las Vegas at the start of the year. With no shortage of innovative technologies on display from the world's leading companies and up-and-coming...more
While we might have seen a pullback in venture capital investment in 2022, one area where investors are not slowing down is betting on artificial intelligence – specifically directing their investment in companies working...more
Last week, the public received its first look at the earnings reports of various cloud providers since the recession bells started ringing. Despite lower than expected revenues, executives remain optimistic about the future...more
Two interwoven challenges come to mind when considering how to successfully patent AI technologies. The first of these challenges is drafting claims whose infringement is detectable despite the black box nature of AI...more
2/28/2020
/ Artificial Intelligence ,
Emerging Technology Companies ,
Intellectual Property Protection ,
Patent Applications ,
Patent Infringement ,
Patent-Eligible Subject Matter ,
Patents ,
Section 101 ,
Section 102 ,
Section 103 ,
Section 112 ,
Software Patents ,
Technology Sector ,
USPTO